News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,466 Results
Type
Article (14191)
Company Profile (282)
Press Release (251993)
Section
Business (79502)
Career Advice (153)
Deals (13225)
Drug Delivery (35)
Drug Development (50437)
Employer Resources (31)
FDA (5714)
Job Trends (5129)
News (144386)
Policy (10032)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (910)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21637)
ALS (60)
Alzheimer's disease (824)
Antibody-drug conjugate (ADC) (86)
Approvals (5728)
Artificial intelligence (107)
Autoimmune disease (10)
Automation (5)
Bankruptcy (104)
Best Places to Work (4562)
BIOSECURE Act (5)
Biosimilars (39)
Biotechnology (232)
Bladder cancer (43)
Brain cancer (19)
Breast cancer (139)
Cancer (1279)
Cardiovascular disease (100)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (304)
Cervical cancer (7)
Clinical research (40849)
Collaboration (495)
Compensation (218)
Complete response letters (13)
COVID-19 (1034)
CRISPR (36)
C-suite (141)
Cystic fibrosis (76)
Data (1331)
Denatured (11)
Depression (28)
Diabetes (122)
Diagnostics (1291)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (76)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (81)
Earnings (29623)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48096)
Executive appointments (396)
FDA (6325)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (462)
Gene editing (87)
Generative AI (9)
Gene therapy (226)
GLP-1 (353)
Government (1074)
Grass and pollen (2)
Guidances (18)
Healthcare (6587)
Huntington's disease (21)
IgA nephropathy (20)
Immunology and inflammation (78)
Indications (18)
Infectious disease (1096)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (55)
Interviews (17)
IPO (7262)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (200)
Leadership (2)
Legal (1388)
Liver cancer (30)
Lung cancer (184)
Lymphoma (81)
Machine learning (1)
Management (7)
Manufacturing (114)
MASH (47)
Medical device (2590)
Medtech (2591)
Mergers & acquisitions (6249)
Metabolic disorders (359)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (57)
Neuropsychiatric disorders (23)
Neuroscience (1187)
NextGen: Class of 2025 (2016)
Non-profit (852)
Northern California (1528)
Now hiring (21)
Obesity (184)
Opinion (100)
Ovarian cancer (59)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (104)
Partnered (6)
Patents (109)
Patient recruitment (66)
Peanut (35)
People (25487)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14421)
Phase II (19006)
Phase III (12013)
Pipeline (678)
Podcasts (46)
Policy (35)
Postmarket research (852)
Preclinical (6058)
Press Release (30)
Prostate cancer (51)
Psychedelics (35)
Radiopharmaceuticals (211)
Rare diseases (270)
Real estate (1414)
Recruiting (12)
Regulatory (8550)
Reports (15)
Research institute (936)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (54)
Series A (91)
Series B (59)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1357)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1971)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (33)
United States (11969)
Vaccines (204)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (2)
Date
Today (75)
Last 7 days (359)
Last 30 days (1609)
Last 365 days (19962)
2025 (4553)
2024 (20558)
2023 (22425)
2022 (26832)
2021 (27810)
2020 (23364)
2019 (16229)
2018 (11744)
2017 (13748)
2016 (11847)
2015 (14357)
2014 (10397)
2013 (7485)
2012 (7534)
2011 (7618)
2010 (7430)
Location
Africa (148)
Alabama (38)
Alaska (2)
Arizona (52)
Arkansas (5)
Asia (17216)
Australia (2916)
California (3480)
Canada (1043)
China (319)
Colorado (134)
Connecticut (143)
Delaware (87)
Europe (37019)
Florida (407)
Georgia (106)
Idaho (16)
Illinois (209)
India (8)
Indiana (85)
Iowa (1)
Japan (68)
Kansas (59)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (441)
Massachusetts (2738)
Michigan (69)
Minnesota (134)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (870)
New Mexico (12)
New York (949)
North Carolina (516)
North Dakota (4)
Northern California (1528)
Ohio (107)
Oklahoma (9)
Oregon (21)
Pennsylvania (663)
Puerto Rico (3)
Rhode Island (15)
South America (208)
South Carolina (4)
Southern California (1357)
Tennessee (25)
Texas (397)
Utah (48)
Virginia (67)
Washington D.C. (28)
Washington State (316)
Wisconsin (13)
266,466 Results for "gyroscope therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
ZAP-X Gyroscopic Radiosurgery Platform Set to Revolutionize Neurosurgery at N. Copernicus Hospital in Gdansk
In a groundbreaking development for brain tumor care in Poland, the Neurosurgery Centre at N. Copernicus Hospital in Gdansk is thrilled to announce the imminent installation of the ZAP-X® Gyroscopic Radiosurgery® platform.
February 6, 2024
·
3 min read
Press Releases
Dongguk University Ilsan Hospital Completes First Brain Tumor Treatments with the ZAP-X Gyroscopic Radiosurgery Platform
July 2, 2024
·
3 min read
Biotech Bay
Kamiyacho Neurosurgical Clinic in Japan Celebrates First Brain Tumor Patient Treated with the New ZAP-X® Gyroscopic Radiosurgery® Platform
ZAP Surgical, a leading innovator in the field of surgical robotics, announced the first patient treatment using the groundbreaking ZAP-X® Gyroscopic Radiosurgery® platform at Kamiyacho Neurosurgical Clinic in Tokyo, Japan.
October 24, 2023
·
3 min read
Biotech Bay
ZAP Surgical Announces Upcoming Installation of Next-Generation ZAP-X Gyroscopic Radiosurgery in Ankara, Turkey
ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, announced that Hacettepe University Hospital in Ankara, Turkey is slated to install the novel ZAP-X® Gyroscopic Radiosurgery® platform before the end of the year.
September 26, 2023
·
3 min read
Biotech Bay
First ZAP-X Gyroscopic Radiosurgery Treatments Commence in France
ZAP Surgical Systems, Inc. today announced that Centre de Cancérologie de la Porte de Saint-Cloud (CCPSC) in Boulogne, France, has initiated patient treatments with the ground-breaking ZAP-X® Gyroscopic Radiosurgery® platform.
May 23, 2023
·
4 min read
Biotech Bay
ZAP Surgical Announces 1,000th Patient Treated with Its Groundbreaking ZAP-X Gyroscopic Radiosurgery Platform
ZAP Surgical Announces 1,000th Patient Treated with Its Groundbreaking ZAP-X Gyroscopic Radiosurgery Platform.
April 19, 2023
·
3 min read
Business
Gyroscope Therapeutics Announces Appointment of Tony Adamis to Board of Directors
Gyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company focused on diseases of the eye, today announced the appointment of biotech industry veteran Anthony (Tony) Adamis, M.D., to the Gyroscope Board of Directors, effective immediately.
December 6, 2021
·
2 min read
Business
Gyroscope Therapeutics Announces Sanofi Investment of Up to $60 Million
Gyroscope Therapeutics Holdings plc today announced that Sanofi, a global biopharmaceutical company, has committed to invest up to USD $60.0 million (GBP £44.5 million) in equity in Gyroscope.
November 8, 2021
·
5 min read
Policy
ZAP Surgical Receives Regulatory Approval in India for Its First ZAP-X Gyroscopic Radiosurgery Platform
ZAP Surgical Systems, Inc. today announced that the company received regulatory approval in India for its first ZAP-X® Gyroscopic Radiosurgery® platform in the form of a No Objection Certificate (NOC) from the Atomic Energy Regulatory Board (AERB).
April 5, 2023
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 26,647
Next
